by Wulff, B.C. et al.
Department of Pathology, The Ohio State University, Columbus, Ohio 43210, USA
Department of Pathology, The Ohio State University, Columbus, Ohio 43210, USA
Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A.
J. Invest. Dermatol. 2008; 10:2467-73